{"schema_version":"secwatch.filing_event.v1","accession":"0000917520-24-000121","form_type":"8-K","ticker":"IART","cik":"0000917520","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","filed_at":"2024-12-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.385238+00:00","generated_at":"2026-05-29T02:40:49.111902+00:00","sec_items":["5.02","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Integra LifeSciences adopts Change in Control Severance Program effective Jan 1, 2025, renewing expiring program","bullets":["Program covers named executives including CFO Lea Knight, with severance multiple of 2x (1.5x for others) base salary plus target bonus.","Qualifying termination (without cause or for good reason) within 2 years after a change in control triggers lump-sum severance, prorated bonus, COBRA for 18 months, and outplacement.","Program term runs through Dec 31, 2025, with automatic extension upon a change in control until 2-year anniversary.","Benefits subject to general release of claims and potential 'best pay cap' reduction for excise tax under Section 4999."],"urls":{"canonical":"https://secwatch.observer/filing/0000917520-24-000121","json":"https://secwatch.observer/filing/0000917520-24-000121.json","markdown":"https://secwatch.observer/filing/0000917520-24-000121.md","text":"https://secwatch.observer/filing/0000917520-24-000121.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000121/0000917520-24-000121-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000121/iart-20241212.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T02:40:49.111902+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}